Response to Paulo et al.: Japanese patients equally likely to benefit from aprepitant for chemotherapy‐induced nausea and vomiting prevention期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Response to Paulo et al.: Japanese patients equally likely to benefit from aprepitant for chemotherapy‐induced nausea and vomiting prevention

Authors:	Toshiaki Takahashi Eishin Hoshi Masakazu Takagi Noriyuki Katsumata Masaaki Kawahara Kenji Eguchi

Affiliation:	1. Thoracic Oncology Division, Shizuoka Cancer Center, Shizuoka;2. Department of Thoracic Surgery, Saitama Cardiovascular and Respiratory Center, Saitama;3. Department of Surgery, Shizuoka General Hospital, Shizuoka;4. Department of Medical Oncology, National Cancer Center Hospital, Tokyo;5. Department of Respiratory Medicine and Medical Oncology, Otemae Hospital, Osaka;6. Division of Medical Oncology, Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan

Abstract:

Keywords: